Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) Sees Large Drop in Short Interest

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totaling 520,263 shares, a decrease of 12.4% from the December 31st total of 594,236 shares. Based on an average daily volume of 141,446 shares, the days-to-cover ratio is presently 3.7 days. Currently, 5.6% of the company’s stock are short sold. Currently, 5.6% of the company’s stock are short sold. Based on an average daily volume of 141,446 shares, the days-to-cover ratio is presently 3.7 days.

Analyst Ratings Changes

ZEPP has been the topic of a number of research analyst reports. Weiss Ratings restated a “sell (d-)” rating on shares of Zepp Health in a report on Wednesday, January 21st. Fundamental Research set a $64.37 price objective on Zepp Health and gave the stock a “buy” rating in a report on Tuesday, November 11th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Zepp Health has a consensus rating of “Hold” and an average target price of $64.37.

Institutional Trading of Zepp Health

A number of large investors have recently added to or reduced their stakes in ZEPP. Public Employees Retirement System of Ohio acquired a new position in shares of Zepp Health during the 3rd quarter worth about $43,000. Oasis Management Co Ltd. bought a new position in Zepp Health during the third quarter worth about $276,000. Centiva Capital LP bought a new position in Zepp Health during the third quarter worth about $538,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Zepp Health during the fourth quarter worth approximately $543,000. Finally, Ariose Capital Management Ltd bought a new stake in Zepp Health in the third quarter valued at approximately $1,269,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

Zepp Health Price Performance

NYSE:ZEPP opened at $17.52 on Wednesday. Zepp Health has a 52-week low of $2.13 and a 52-week high of $61.85. The company has a market cap of $253.97 million, a P/E ratio of -4.26 and a beta of 1.47. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.09. The stock’s 50-day simple moving average is $26.15 and its 200 day simple moving average is $33.68.

Zepp Health (NYSE:ZEPP) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.04) earnings per share for the quarter. Zepp Health had a negative net margin of 28.28% and a negative return on equity of 21.45%. The company had revenue of $75.79 million during the quarter.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.